Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Reischies, FM; Raggam, RB; Prattes, J; Krause, R; Eigl, S; List, A; Quehenberger, F; Strenger, V; Wölfler, A; Hoenigl, M.
Urine Galactomannan-to-Creatinine Ratio for Detection of Invasive Aspergillosis in Patients with Hematological Malignancies.
J Clin Microbiol. 2016; 54(3):771-774
Doi: 10.1128/JCM.02969-15
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Hönigl Martin
-
Reischies-Meikl Frederike Marie Josefine
- Co-Autor*innen der Med Uni Graz
-
Eigl Susanne
-
Krause Robert
-
Prattes Jürgen
-
Quehenberger Franz
-
Raggam Reinhard Bernd
-
Strenger Volker
-
Wölfler Albert
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Galactomannan (GM) testing of urine specimens may provide important advantages, compared to serum testing, such as easy noninvasive sample collection. We evaluated a total of 632 serial urine samples from 71 patients with underlying hematological malignancies and found that the urine GM/creatinine ratio, i.e., (urine GM level × 100)/urine creatinine level, which takes urine dilution into account, reliably detected invasive aspergillosis and may be a promising diagnostic tool for patients with hematological malignancies. (This study has been registered at ClinicalTrials.gov under registration no. NCT01576653.).
Copyright © 2016, American Society for Microbiology. All Rights Reserved.
- Find related publications in this database (using NLM MeSH Indexing)
-
Aspergillosis - diagnosis
-
Aspergillosis - etiology
-
Aspergillosis - urine
-
Biomarkers -
-
Creatinine - blood
-
Creatinine - urine
-
Female -
-
Hematologic Neoplasms - complications
-
Humans -
-
Male -
-
Mannans - blood
-
Mannans - urine
-
Middle Aged -
-
ROC Curve -
-
Reproducibility of Results -